It seems early in the oversight of the new FDA Commissioner and Deputy Commissioner to the agency turning a corner, or maybe not. There have been two indications of possible increased enforcement that have emerged in the past few days … Continue reading
We have had 3 days in a row without rain. That is most welcome. Today, I fear, we may lose our streak. It has heated up in Washington and so has the debate on healthcare reform. Another public figure who … Continue reading
It is no state secret that the pharmaceutical industry is seriously lagging behind other industries – even other highly regulated industries – in making use of digital media to engage and support their stakeholders. There are still many, if not … Continue reading
Tomorrow, the FDA is holding a hearing on transparency here in Washington, D.C and have issued their ground rules for participation. The event is certainly a noble gesture and one does not have reason to expect that this time around, FDA is anything … Continue reading
I happen to think that no element of new and emerging media is more important than Twitter – something that should be apparent to anyone involved in communications. Enter into evidence the role that Twitter played in many recent news … Continue reading
